-
52001XC1228(02)
Summary of Community decisions on marketing authorisations in respect of medicinal products from 15 November to 15 December 2001 (Decisions taken pursuant to Article 14 of Directive 75/319/EEC or Article 22 of Directive 81/881/EEC)
OJ C 371, 28.12.2001, p. 11–12 (ES, DA, DE, EL, EN, FR, IT, NL, PT, FI, SV)
-
32000L0038
Commission Directive 2000/38/EC of 5 June 2000 amending Chapter Va (Pharmacovigilance) of Council Directive 75/319/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products (Text with EEA relevance)
OJ L 139, 10.6.2000, p. 28–30 (ES, DA, DE, EL, EN, FR, IT, NL, PT, FI, SV)
-
31998R1146
Commission Regulation (EC) No 1146/98 of 2 June 1998 amending Regulation (EC) No 541/95 concerning the examination of variations in the terms of a marketing authorisation granted by a competent authority of a Member State
OJ L 159, 3.6.1998, p. 31–34 (ES, DA, DE, EL, EN, FR, IT, NL, PT, FI, SV)
-
31995R0541
Commission Regulation (EC) No 541/95 of 10 March 1995 concerning the examination of variations to the terms of a marketing authorization granted by a competent authority of a Member State
OJ L 55, 11.3.1995, p. 7–14 (ES, DA, DE, EL, EN, FR, IT, NL, PT, FI, SV)
-
31991L0356
Commission Directive 91/356/EEC of 13 June 1991 laying down the principles and guidelines of good manufacturing practice for medicinal products for human use
OJ L 193, 17.7.1991, p. 30–33 (ES, DA, DE, EL, EN, FR, IT, NL, PT)
-
51988DC0143
REPORT FROM THE COMMISSION ON THE ACTIVITIES OF THE COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS ( ARTICLE 15 PAR 1 OF DIRECTIVE 75/319/EEC AS AMENDED )
/* COM/88/143FINAL */
|
